Neoadjuvant Chemotherapy Prior to Surgery Improves Outcomes in UTUC
Latest findings are from one of the largest experiences of neoadjuvant chemotherapy in upper tract urothelial carcinoma to date.
Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men
Findings based on men’s weight at age 18 years and cancer incidence during more than 30 years.
Patient Perspective on Communication, Symptom Screening in Metastatic Lung Cancer
An interview study with patients with mNSCLC revealed patients’ values regarding information about their disease, its treatment, and their prognosis and expectations.
High-Dose Cytarabine, With or Without Vorinostat, Does Not Improve Outcomes in AML
Researchers sought to determine whether high-dose cytarabine, with or without vorinostat, is superior to standard cytarabine in previously untreated AML.
Antibiograms, Intracorporeal Diversion Cut Infection Risks After Radical Cystectomy
Antibiograms help guide the selection of the best empiric antimicrobial treatment when microbiology culture and susceptibility results are pending.
Prediction Model for Invasive Breast Cancer Improved With Additional Risk Factors
Body mass index was associated with largest improvement in estimated risk for individual women.
Acupuncture, Massage Offer Equivalent Symptom Management in Advanced Cancer
Randomized trial found acupuncture and massage beneficial in relieving pain in patients with advanced pain, with little difference in effect between the 2 modalities.
Gemcitabine-Docetaxel May Be a Feasible Alternative to BCG for High-Risk NMIBC
Investigators report their early clinical experience using intravesical sequential gemcitabine-docetaxel as first-line therapy for high-risk nonmuscle-invasive bladder cancer.
Radical Cystectomy Added to Chemotherapy Ups Survival in cN1 Bladder Cancer
Investigators report a 46% lower risk for death compared with chemotherapy alone.
Adverse Events Up With Immune Checkpoint Blockade Added to Periop Cancer Therapy
Increase seen in incidence of grade 3 to 4 treatment-related adverse events, adverse events leading to treatment discontinuation.
- Loading...
